On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Drug discovery remains a very long and costly process with reducing attrition a major objective. We have shown previously that using human genetics evidence may increase the chance of success in the clinic for drug targets. In addition, genomics technologies that can measure omics layers or perturb the genome at scale can also be used to identify and validate new drug targets and investigate biology at a systems level. In this talk, using examples, I will describe how genetics and genomics data with computational biology analyses are currently being used in drug discovery and the importance of biological context.